DESIGN OF MULTIMERIC INTERLEUKIN-2 RECEPTOR ECTODOMAINS
多聚白细胞介素 2 受体胞外域的设计
基本信息
- 批准号:2457766
- 负责人:
- 金额:$ 20.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-05-01 至 2002-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Interleukin-2 is a helical cytokine that has found wide spread
clinical use in the treatment of some malignancies and for infectious
diseases including HIV infection. The interleukin-2 receptor (IL-2R) is one
of the most complex receptor systems of the large family of hematopoietin
receptors. It may exist in a variety of affinity states depending upon the
participation of different combinations of three separate cell surface
subunits: IL-2Ralpha, beta and gamma. These subunits function in the form
of two specific heterodimers (IL-2Ralpha beta) and (IL-2Rbeta gamma) and one
heterotrimer (IL-2Ralpha beta gamma). Each of these cell surface assemblies
performs a distinct physiologic function. It is the cooperativity of these
subunits during ligand capture and signal transmission that provides the key
to understanding exploiting the therapeutic potential of IL-2. This project
was the first to propose and implement the use of coiled-coil recognition
sequences (Leu Zippers) for the solution assembly of complex receptor
systems. During the initial project period, the feasibility of this
approach was established and methods were developed for the expression and
characterization of soluble IL-2R coiled-coil complexes. Coiled-coil
mediated solution assembly generated heteromeric IL-2R complexes that bound
ligand in a fashion that resembled their cell surface counterparts. These
complexes are already proving useful for IL-2 structure/function analysis.
This proposal is a request for continuation of this work with the goals of
stable solution assembly and complete characterization of all three of the
functional heteromeric IL-2R complexes. The Specific Aims of this project
are: 1. To express, isolate and characterize the two functional IL-2
receptor heterodimers (IL-2Ralpha beta pseudo high affinity and IL-2R beta
gamma intermediate affinity receptors) as stable coiled-coil complexes. 2.
To express, isolate and characterize the presumed IL-2 receptor
heterotrimeric high affinity receptor (IL-2Ralpha beta gamma) as a stable
coiled-coil complex. 3. To determine the equilibrium and kinetic ligand
binding characteristics of each receptor complex. 4. To obtain detailed
structure-activity data on these complexes by co-crystallizing them with
IL-2 and determining their X-ray structures to high resolution.
描述:白细胞介素-2是一种螺旋细胞因子,
在治疗某些恶性肿瘤和感染性疾病中的临床应用
包括艾滋病毒感染在内的疾病。 白细胞介素-2受体(IL-2 R)是一种
最复杂的受体系统
受体。 它可以以各种亲和力状态存在,这取决于
三个独立细胞表面的不同组合的参与
亚基:IL-2 R α、β和γ。 这些亚单位的功能是
两种特异性异二聚体(IL-2 R α β)和(IL-2 R β γ)以及一种
异源三聚体(IL-2 R α β γ)。 每一个细胞表面组件
有着独特的生理功能 正是这些合作性
在配体捕获和信号传递过程中,
来理解利用IL-2的治疗潜力。 这个项目
是第一个提出并实施使用螺旋线圈识别的人
用于复杂受体的溶液组装的序列(Leu Zippers)
系统. 在项目初期,
建立了方法,并开发了表达和
可溶性IL-2 R卷曲螺旋复合物的表征。 卷曲螺旋
介导的溶液组装产生异聚IL-2 R复合物,
配体以类似于它们的细胞表面对应物的方式。 这些
复合物已经证明可用于IL-2结构/功能分析。
本提案要求继续开展这项工作,目标是
稳定的解决方案组装和所有三个完整的表征,
功能性异聚体IL-2 R复合物。 本项目的具体目标
是:1. 表达、分离和鉴定两种功能性IL-2
受体异二聚体(IL-2 R α β假高亲和力和IL-2 R β假高亲和力)
γ中间亲和受体)作为稳定的卷曲螺旋复合物。 2.
表达、分离和鉴定假定的IL-2受体
异源三聚体高亲和力受体(IL-2 R α β γ)作为稳定的
卷曲螺旋复合体 3. 为了确定平衡和动力学配体
每个受体复合物的结合特征。 4. 获得详细
这些复合物的结构-活性数据通过共结晶它们与
IL-2,并确定其X射线结构的高分辨率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS L CIARDELLI其他文献
THOMAS L CIARDELLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS L CIARDELLI', 18)}}的其他基金
AFFINITY MATURATION OF IL-2 AND RELATED PEPTIDES
IL-2 和相关肽的亲和力成熟
- 批准号:
2459627 - 财政年份:1995
- 资助金额:
$ 20.6万 - 项目类别:
AFFINITY MATURATION OF IL-2 AND RELATED PEPTIDES
IL-2 和相关肽的亲和力成熟
- 批准号:
2192043 - 财政年份:1995
- 资助金额:
$ 20.6万 - 项目类别:
AFFINITY MATURATION OF IL-2 AND RELATED PEPTIDES
IL-2 和相关肽的亲和力成熟
- 批准号:
2192042 - 财政年份:1995
- 资助金额:
$ 20.6万 - 项目类别:
相似海外基金
CAREER: Unveiling the structure and stability of prenucleation clusters and their roles in crystallization pathway and final crystal structure
职业:揭示成核前团簇的结构和稳定性及其在结晶途径和最终晶体结构中的作用
- 批准号:
2338173 - 财政年份:2024
- 资助金额:
$ 20.6万 - 项目类别:
Continuing Grant
CAREER: Nanoscale Resolution of Near-Interface Crystallization in Multicomponent Semicrystalline Polymeric Materials
职业:多组分半晶聚合物材料中近界面结晶的纳米级分辨率
- 批准号:
2338613 - 财政年份:2024
- 资助金额:
$ 20.6万 - 项目类别:
Continuing Grant
CAREER: Evaluating Theories of Polymer Crystallization by Directly Calculating the Nucleation Barrier in a Polymer Melt
职业:通过直接计算聚合物熔体中的成核势垒来评估聚合物结晶理论
- 批准号:
2338690 - 财政年份:2024
- 资助金额:
$ 20.6万 - 项目类别:
Continuing Grant
Anti-solvent crystallization及び ED-Rプロセスを用いる新規LiB再生システムの構築
采用反溶剂结晶和ED-R工艺构建新型LiB再生系统
- 批准号:
24K08133 - 财政年份:2024
- 资助金额:
$ 20.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of the active fiber-type device by glass crystallization for next-generation light control
通过玻璃结晶创建用于下一代光控制的有源光纤型装置
- 批准号:
22KJ0290 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Understanding Plant Based Fat Crystallization for the Design of Vegan and Low Carbon Footprint Chocolate
了解植物脂肪结晶在纯素和低碳足迹巧克力设计中的应用
- 批准号:
BB/Y512692/1 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
Training Grant
General applicability and quantitative predictability of complex population-based crystallization models
基于复杂群体的结晶模型的普遍适用性和定量可预测性
- 批准号:
2903595 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
Studentship
Elucidation of the origin of zeolite crystallization and innovation of production methods
沸石结晶起源的阐明及生产方法的创新
- 批准号:
23H05454 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Biopharmaceuticals purification by continuous membrane-assisted crystallization achieving lower cost and intensified processes (BIOPURE)
通过连续膜辅助结晶进行生物制药纯化,实现更低的成本和强化工艺 (BIOPURE)
- 批准号:
10082780 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
EU-Funded
Development of a Novel Method for Producing Pharmaceutical Multi-Phase Solid Using Melt Crystallization
开发利用熔融结晶生产药物多相固体的新方法
- 批准号:
23KJ0860 - 财政年份:2023
- 资助金额:
$ 20.6万 - 项目类别:
Grant-in-Aid for JSPS Fellows